• Explore /
  • Poster
  • / A phase Ib study of NUC-3373 in combination with standard therapies in advanced/metastatic colorectal cancer (NuTide:302).

A phase Ib study of NUC-3373 in combination with standard therapies in advanced/metastatic colorectal cancer (NuTide:302).

Abstract Poster

Authors

Andrew Coveler

Andrew L. Coveler

Seattle Cancer Care Alliance/University of Washington, Seattle, WA

Andrew L. Coveler , Farasat Kazmi , Kristen Keon Ciombor , Janet Graham , Lisa Jane Rodgers , Michelle Myers , Jordan Berlin , Sarah Patricia Blagden , T.R. Jeffry Evans

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03428958

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 93)

DOI

10.1200/JCO.2021.39.3_suppl.93

Abstract #

93

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Atsushi Ishiguro

First Author: T.R. Jeffry Evans

First Author: Sarah Patricia Blagden

First Author: Benoist Chibaudel